Letter | Published:

Opiate receptors influence vasopressin release from nerve terminals in rat neurohypophysis

Abstract

A previous report described the existence of substantial amounts of enkephalin immunoreacitivity and the occurrence of nerve terminals containing an enkephalin-like material in the pars nervosa of rat pituitary1. It was suggested that an enkephalin innervation of the pars nervosa originating from the magnocellular hypothalamic nuclei might regulate the secretion of neurohypophyseal hormones. The results of the present studies support this hypothesis, as we find that a stable enkephalin analogue (D-Ala2, D-Leu5-enkephalin) inhibits the calcium-dependent release of vasopressin evoked by electrical stimulation of the rat pituitary stalk in vitro. A similar inhibition of the stimulus-evoked vasopressin release is caused by morphine and β-endorphin, and the inhibitory effects of the enkephalin analogue can be reversed by naloxone. These findings suggest the possible existence of inhibitory opiate receptors on the terminals of vasopressin fibres in the pars nervosa.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Rossier, J. et al. Nature 277, 653–655 (1979).

  2. 2

    Douglas, W. W. & Poisner, A. M. J. Physiol., Lond. 172, 1–18 (1964).

  3. 3

    Dreifuss, J. J., Kalnins, I., Kelly, J. S. & Ruf, K. B. J. Physiol., Lond. 215, 805–817 (1971).

  4. 4

    Dutton, A. & Dyball, R. E. J. J. Physiol., Lond. 290, 433–440 (1979).

  5. 5

    Beddell, C. R. et al. Proc. R. Soc. B198, 249–265 (1977).

  6. 6

    Simantov, R. & Snyder, S. H. Brain Res. 124, 178–184 (1977).

  7. 7

    Minchin, M. C. W. & Nordmann, J. J. Brain Res. 90, 75–84 (1975).

  8. 8

    Patel, Y. C., Zingg, H. H. & Dreifuss, J. J. Nature 267, 852–853 (1977).

  9. 9

    De Bodo, R. C. J. Pharmac. exp. Ther. 82, 74–85 (1944).

  10. 10

    Duke, H. N., Pickford, M. & Watt, J. A. Q. Jl exp. Physiol. 36, 149–158 (1951).

  11. 11

    Bissett, G. W., Chowdrey, H. S. & Feldberg, W. Br. J. Pharmac. 62, 370–371 (1978).

  12. 12

    Weitzman, R. E., Fisher, D. A., Minick, S., Ling, N. & Guillemin, R. Endocrinology 101, 1643–1646 (1977).

  13. 13

    Pablo Huidibro-Toro, J., Huidobro, F. & Croxatto, R. Life Sci. 24, 697–704 (1979).

  14. 14

    van Wimersma Greidanus, T. B. et al. Life Sci. 24, 579–586 (1979).

  15. 15

    Aziz, L. A., Forsling, M. L. & Woolf, C. J. J. Physiol. Lond. (in the press).

  16. 16

    Pittman, Q. J., Hatton, J. D. & Bloom, F. E. Soc. Neurosci. Abstr. 5, 233 (1979).

  17. 17

    Clarke, G., Wood, P., Merick, L. & Lincoln, D. W. Nature 282, 746–748 (1979).

  18. 18

    Kosterlitz, H. W. & Waterfield, A. A. A. Rev. Pharmac. 15, 29–47 (1975).

  19. 19

    Jessell, T. M. & Iversen, L. L. Nature 268, 549–551 (1977).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.